Moderna's COVID Vaccine Holds Up for Kids 6-11 Years
(MedPage Today) -- Moderna's COVID vaccine (Spikevax) was safe, effective, and produced an immune response in children ages 6-11, an interim analysis of a phase II/III trial found.
Two 50 μg doses of vaccine -- half the dose of Moderna...
Source: MedPage Today Public Health - Category: American Health Source Type: news
More News: American Health | Children | Covid Vaccine | International Medicine & Public Health | Vaccines